Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer treatment with palliative intent.
communication
decision-making
interprofessional
palliative oncology
physician attitudes
Journal
ESMO open
ISSN: 2059-7029
Titre abrégé: ESMO Open
Pays: England
ID NLM: 101690685
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
30
01
2022
revised:
08
04
2022
accepted:
13
04
2022
pubmed:
22
5
2022
medline:
12
7
2022
entrez:
21
5
2022
Statut:
ppublish
Résumé
Weighing risks and benefits is currently the primary criterion for decisions regarding systemic anticancer treatment (SACT) in far advanced cancer patients, also in the modern immunotherapy- and molecular-targeted driven oncology. Decision aids rarely include substantially key concepts of early integrated palliative care (PC) and communication science. We compiled decisional factors (DFs) important for guiding the use of SACT with palliative intent (SACT-PI) and explored these DFs regarding their applicability in routine clinical care. Clinician (participants: n = 28) and patient (n = 15) focus groups were conducted in an integrated oncology and PC setting. Thematic analysis was used to identify DFs. A Delphi survey of clinicians ranked the importance of DFs in routine decision-making. DFs were aligned with elements of the typical decision-making process, resulting in an eight-step guide for making SACT-PI decisions in clinical practice. Eight focus groups revealed 55 DFs relating to established topics like providing information and risk-benefit analysis, as well as to PC topics like patients' attitudes, beliefs, and hopes; patient-physician interaction; and physician attitudes. Agreement on the relative importance was reached for 34 (62%) of 55 DFs, assigned to five elements: patient/family, clinicians/system, patient-clinician-interaction, information/patient education, risk-benefit weighting/actual decision. These themes are embedded in a potential clinically useful SACT-PI Decision Framework, which includes eight steps: assess, educate, verify, reflect, discuss, weigh, pause, and decide. The SACT-PI Decision Framework integrates subjective patient factors, interpersonal factors, and PC issues into decision-making. Our findings complement existing decision aids and prompt lists by framing DFs in the context of SACT-PI and enforce the decision 'process', not the decision act. Further research is needed to explore the relative importance of DFs in specific patient situations and test structured decision-making processes, such as our SACT-PI Decision Framework, against standard care.
Sections du résumé
BACKGROUND
Weighing risks and benefits is currently the primary criterion for decisions regarding systemic anticancer treatment (SACT) in far advanced cancer patients, also in the modern immunotherapy- and molecular-targeted driven oncology. Decision aids rarely include substantially key concepts of early integrated palliative care (PC) and communication science. We compiled decisional factors (DFs) important for guiding the use of SACT with palliative intent (SACT-PI) and explored these DFs regarding their applicability in routine clinical care.
PATIENTS AND METHODS
Clinician (participants: n = 28) and patient (n = 15) focus groups were conducted in an integrated oncology and PC setting. Thematic analysis was used to identify DFs. A Delphi survey of clinicians ranked the importance of DFs in routine decision-making. DFs were aligned with elements of the typical decision-making process, resulting in an eight-step guide for making SACT-PI decisions in clinical practice.
RESULTS
Eight focus groups revealed 55 DFs relating to established topics like providing information and risk-benefit analysis, as well as to PC topics like patients' attitudes, beliefs, and hopes; patient-physician interaction; and physician attitudes. Agreement on the relative importance was reached for 34 (62%) of 55 DFs, assigned to five elements: patient/family, clinicians/system, patient-clinician-interaction, information/patient education, risk-benefit weighting/actual decision. These themes are embedded in a potential clinically useful SACT-PI Decision Framework, which includes eight steps: assess, educate, verify, reflect, discuss, weigh, pause, and decide.
CONCLUSIONS
The SACT-PI Decision Framework integrates subjective patient factors, interpersonal factors, and PC issues into decision-making. Our findings complement existing decision aids and prompt lists by framing DFs in the context of SACT-PI and enforce the decision 'process', not the decision act. Further research is needed to explore the relative importance of DFs in specific patient situations and test structured decision-making processes, such as our SACT-PI Decision Framework, against standard care.
Identifiants
pubmed: 35597176
pii: S2059-7029(22)00116-8
doi: 10.1016/j.esmoop.2022.100496
pmc: PMC9271509
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
100496Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have declared no conflicts of interest.
Références
Patient Educ Couns. 2014 Mar;94(3):291-309
pubmed: 24305642
Patient Educ Couns. 2014 Oct;97(1):30-7
pubmed: 25023487
Support Care Cancer. 2008 Aug;16(8):935-42
pubmed: 17968597
J Clin Oncol. 2012 Jul 10;30(20):2538-44
pubmed: 22614979
Oncologist. 2019 Nov;24(11):e1190-e1196
pubmed: 31015314
JAMA Oncol. 2020 Aug 1;6(8):1265-1270
pubmed: 32672806
Int J Palliat Nurs. 2003 May;9(5):202-7
pubmed: 12819597
Health Expect. 2000 Jun;3(2):125-136
pubmed: 11281919
Oncologist. 2020 Mar;25(3):e578-e588
pubmed: 32162796
Oncologist. 2013;18(1):90-6
pubmed: 23287883
Support Care Cancer. 2019 Apr;27(4):1375-1382
pubmed: 30145739
BMC Cancer. 2021 Mar 6;21(1):236
pubmed: 33676431
Health Expect. 2015 Dec;18(6):2570-83
pubmed: 24975503
Can J Nurs Res. 1997 Fall;29(3):21-43
pubmed: 9505581
Soc Sci Med. 2005 Nov;61(10):2252-64
pubmed: 15922501
Patient Educ Couns. 2019 Nov;102(11):1957-1960
pubmed: 31230873
J Palliat Med. 2010 May;13(5):595-603
pubmed: 20491550
Palliat Med. 2011 Apr;25(3):242-61
pubmed: 21273220
Health Serv Res. 2002 Oct;37(5):1419-39
pubmed: 12479504
JAMA Oncol. 2015 Sep;1(6):778-84
pubmed: 26203912
Lancet Oncol. 2011 May;12(5):489-95
pubmed: 21296615
BMJ Open. 2014 Jun 26;4(6):e005745
pubmed: 24969786
Oncologist. 2019 Sep;24(9):e960-e967
pubmed: 30975922
Eur J Cancer Care (Engl). 2014 Nov;23(6):762-72
pubmed: 24840999
BMJ. 1995 Jul 29;311(7000):299-302
pubmed: 7633241
Soc Sci Med. 1997 Mar;44(5):681-92
pubmed: 9032835
Ann Oncol. 2016 Aug;27(8):1378-81
pubmed: 27457308
J Pain Symptom Manage. 2011 Feb;41(2):456-68
pubmed: 20832987
Soc Sci Med. 2013 Jan;77:156-63
pubmed: 23219164
J Clin Oncol. 2015 May 1;33(13):1438-45
pubmed: 25800768
J Clin Oncol. 2011 Mar 10;29(8):1029-35
pubmed: 21282548
CA Cancer J Clin. 2018 Sep;68(5):356-376
pubmed: 30277572
Crit Rev Oncol Hematol. 2016 Mar;99:286-98
pubmed: 26819138
BMJ. 2014 Mar 04;348:g1219
pubmed: 24594868
Patient Educ Couns. 2016 Jul;99(7):1146-1155
pubmed: 26873544
Support Care Cancer. 2013 Dec;21(12):3293-300
pubmed: 23887739
Psychooncology. 2021 Apr;30(4):571-580
pubmed: 33245150
N Engl J Med. 2012 Oct 25;367(17):1616-25
pubmed: 23094723
J Thorac Oncol. 2019 Feb;14(2):176-183
pubmed: 30336324
Curr Treat Options Oncol. 2020 Jan 16;21(1):5
pubmed: 31950387
J Clin Oncol. 2008 Aug 10;26(23):3867-73
pubmed: 18688054
Oncologist. 2017 Sep;22(9):1117-1124
pubmed: 28596446
Lancet Oncol. 2014 Mar;15(3):e112-8
pubmed: 24534294
Ann Oncol. 2016 Feb;27(2):324-32
pubmed: 26646758
Eur J Cancer Care (Engl). 2016 Jul;25(4):580-91
pubmed: 26676876
J Clin Oncol. 2017 Jan;35(1):96-112
pubmed: 28034065
J Oncol Pract. 2014 May;10(3):e137-41
pubmed: 24594680
J Clin Oncol. 2003 Apr 1;21(7):1379-82
pubmed: 12663730
ESMO Open. 2021 Jun;6(3):100147
pubmed: 33984671
Eur J Cancer. 2020 Jan;124:186-193
pubmed: 31812934
Palliat Med. 2013 Sep;27(8):779-88
pubmed: 23630055
Educ Prim Care. 2021 Mar;32(2):91-99
pubmed: 33375910
Support Care Cancer. 2012 Aug;20(8):1787-95
pubmed: 21947560
BMJ. 2014 May 14;348:g3178
pubmed: 25134115
Eur J Cancer. 2016 Dec;69:110-118
pubmed: 27821313
Eur J Oncol Nurs. 2015 Dec;19(6):740-6
pubmed: 26059323
Psychooncology. 2013 Dec;22(12):2771-8
pubmed: 23839783
BMJ. 2008 Aug 07;337:a1035
pubmed: 18687726
J Oncol Pract. 2016 Sep;12(9):e828-38
pubmed: 27531376
Support Care Cancer. 2018 Apr;26(4):1215-1220
pubmed: 29090384
Ann Oncol. 2013 Sep;24(9):2444-9
pubmed: 23704195
PLoS One. 2011;6(6):e20476
pubmed: 21694759
Patient Educ Couns. 2014 Jan;94(1):4-9
pubmed: 24268920
Anticancer Res. 2012 Sep;32(9):4085-90
pubmed: 22993365
Health Expect. 2008 Mar;11(1):35-45
pubmed: 18297781
J Clin Oncol. 2011 May 20;29(15):2077-84
pubmed: 21483008
J Palliat Med. 2011 Apr;14(4):459-64
pubmed: 21417739
Psychooncology. 2018 Jul;27(7):1833-1839
pubmed: 29655277
Oncology (Williston Park). 2012 Jan;26(1):37-43, 46
pubmed: 22393795
Ann Oncol. 2015 Aug;26(8):1547-73
pubmed: 26026162
BMJ. 2017 Apr 18;357:j1744
pubmed: 28420639
Oncologist. 2021 Jun;26(6):e1073-e1082
pubmed: 33555084
Psychooncology. 2012 Apr;21(4):392-9
pubmed: 21280138
Am Soc Clin Oncol Educ Book. 2018 May 23;38:787-794
pubmed: 30231384
Cochrane Database Syst Rev. 2017 Jun 12;6:CD011129
pubmed: 28603881
J Adv Nurs. 2000 Oct;32(4):1008-15
pubmed: 11095242
Palliat Med. 2018 Apr;32(4):870-880
pubmed: 29235415
J Clin Oncol. 2004 Nov 1;22(21):4401-9
pubmed: 15514382
Psychooncology. 2021 Oct;30(10):1663-1679
pubmed: 34146446
Eur J Cancer Care (Engl). 2019 May;28(3):e13079
pubmed: 31066142
BMC Palliat Care. 2018 May 11;17(1):74
pubmed: 29747628
Support Care Cancer. 2016 Jan;24(1):33-41
pubmed: 25903929
J Clin Oncol. 2010 May 1;28(13):2310-3
pubmed: 20194838
BMC Med. 2015 Oct 13;13:263
pubmed: 26464185
Int J Palliat Nurs. 2009 Aug;15(8):405-11
pubmed: 19773705
J Palliat Care. 2021 Apr;36(2):78-86
pubmed: 33241732
Ann Oncol. 2017 Sep 01;28(9):2057-2066
pubmed: 28911084
J Med Ethics. 2000 Oct;26(5):358-62
pubmed: 11055039
J Clin Oncol. 2008 Aug 10;26(23):3860-6
pubmed: 18688053
Med Decis Making. 2008 Nov-Dec;28(6):829-33
pubmed: 19020341
BMJ. 2017 Jul 4;357:j2925
pubmed: 28676557
JAMA. 2008 Oct 8;300(14):1665-73
pubmed: 18840840
J Clin Oncol. 2011 Feb 20;29(6):755-60
pubmed: 21263086
Curr Opin Oncol. 2012 Jul;24(4):381-90
pubmed: 22572724
J Clin Oncol. 2013 Feb 1;31(4):461-7
pubmed: 23248245